ADBiotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	46,149	33,212	19,012	29,935	30,712	45,092
Market Cap Growth	130.56%	74.69%	-36.49%	-2.53%	-31.89%	20.26%
Enterprise Value	52,912	32,727	27,330	39,459	35,183	-
Last Close Price	2345.00	2030.00	2080.00	3275.00	3360.00	9100.00
PE Ratio	-	-	-	-	11.39	-
PS Ratio	3.69	2.58	1.71	2.86	2.89	3.81
PB Ratio	3.23	2.16	3.99	2.38	1.90	8.83
P/TBV Ratio	3.01	2.17	5.88	2.66	1.90	8.84
P/FCF Ratio	-	-	-	398.99	-	-
P/OCF Ratio	60.21	-	-	95.05	-	-
EV/Sales Ratio	4.23	2.54	2.45	3.77	3.31	-
EV/FCF Ratio	-3.51	-	-	525.92	-	-
Debt / Equity Ratio	0.94	1.09	2.51	1.08	0.79	2.58
Debt / FCF Ratio	-	-	-	181.40	-	-
Net Debt / Equity Ratio	0.55	0.35	2.16	0.33	0.26	2.04
Net Debt / EBITDA Ratio	-2.28	-2.10	-3.33	-1.15	-0.97	-11.50
Net Debt / FCF Ratio	-0.52	-0.31	-2.40	55.93	-0.44	-1.81
Asset Turnover	0.37	0.36	0.44	0.35	0.41	0.60
Inventory Turnover	3.47	3.32	3.07	2.78	2.97	3.52
Quick Ratio	0.28	0.46	0.35	0.98	0.89	0.50
Current Ratio	0.49	0.70	0.62	1.19	1.20	0.69
Return on Equity (ROE)	-80.20%	-33.04%	-103.66%	-37.78%	25.33%	-36.92%
Return on Assets (ROA)	-8.03%	-6.12%	-10.06%	-10.09%	-11.98%	-4.88%
Return on Capital Employed (ROCE)	-24.80%	-18.70%	-43.00%	-28.40%	-25.90%	-18.70%
Earnings Yield	-18.05%	-9.95%	-41.83%	-9.57%	8.78%	-5.91%
FCF Yield	-32.67%	-51.58%	-22.54%	0.25%	-30.34%	-12.74%
Buyback Yield / Dilution	-55.08%	-31.40%	0.00%	9.33%	-31.17%	-53.77%